Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

celgene australia pty ltd - thalidomide -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

celgene australia pty ltd - thalidomide -

Ausztrália - angol - Department of Health (Therapeutic Goods Administration)

link medical products pty ltd t/a link pharmaceuticals - dapsone -

Japán - angol - すりの適正使用協議会 RAD-AR Council, Japan

fujimoto pharmaceutical corporation - thalidomide - capsule with orange opaque cap imprinted with "サリドマイド" and white opaque body imprinted with "サレド100", major axis: approx. 18.0 mm, minor axis: approx. 6.3 mm

Japán - angol - すりの適正使用協議会 RAD-AR Council, Japan

fujimoto pharmaceutical corporation - thalidomide - capsule with green opaque cap imprinted with "サリドマイド" and white opaque body imprinted with "サレド25", major axis: approx. 14.3 mm, minor axis: approx. 5.3 mm

Japán - angol - すりの適正使用協議会 RAD-AR Council, Japan

fujimoto pharmaceutical corporation - thalidomide - capsule with blue opaque cap imprinted with "サリドマイド" and white opaque body imprinted with "サレド50", major axis: approx. 14.3 mm, minor axis: approx. 5.3 mm

Ausztrália - angol - APVMA (Australian Pesticides and Veterinary Medicines Authority)

nutrien ag solutions limited - procymidone - suspension concentrate - procymidone carboximide active 500.0 g/l - fungicide

Malajzia - angol - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

zulat pharmacy sdn. bhd. - clofazimine -

Új-Zéland - angol - Medsafe (Medicines Safety Authority)

celgene limited, a bristol myers squibb company - thalidomide 100mg - capsule - 100 mg - active: thalidomide 100mg excipient: gelatin magnesium stearate pregelatinised maize starch - · thalomid in combination with melphalan and prednisone is indicated for the treatment of patients with untreated multiple myeloma aged 65 years or older, or ineligible for high dose chemotherapy. · thalomid in combination with dexamethasone is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue, for the treatment of patients with untreated multiple myeloma. ·thalomid, as monotherapy, is indicated for the treatment of multiple myeloma after failure of standard therapies.

Új-Zéland - angol - Medsafe (Medicines Safety Authority)

celgene limited, a bristol myers squibb company - thalidomide 150mg - capsule - 150 mg - active: thalidomide 150mg excipient: gelatin magnesium stearate pregelatinised maize starch - · thalomid in combination with melphalan and prednisone is indicated for the treatment of patients with untreated multiple myeloma aged 65 years or older, or ineligible for high dose chemotherapy. · thalomid in combination with dexamethasone is indicated for induction therapy prior to high dose chemotherapy with autologous stem cell rescue, for the treatment of patients with untreated multiple myeloma. ·thalomid, as monotherapy, is indicated for the treatment of multiple myeloma after failure of standard therapies.